What is SYBX stock price today?

SYBX (Synlogic Inc) stock is trading at $0.69 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is SYBX stock going up or down today?

SYBX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy SYBX stock now?

The decision to buy SYBX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is SYBX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for SYBX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is SYBX stock overvalued or undervalued?

Use our DCF valuation calculator to determine if SYBX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is SYBX's P/E ratio?

P/E ratio data for SYBX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is SYBX's market cap?

SYBX (Synlogic Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is SYBX's price to book ratio?

SYBX trades at a price-to-book (P/B) ratio of 0.63, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does SYBX pay dividends?

SYBX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is SYBX's dividend yield?

SYBX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is SYBX stock a good long-term investment?

SYBX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is SYBX's revenue growth rate?

SYBX has shown revenue growth of -1.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for SYBX are available on our dashboard with complete income statement analysis.

What are the risks of investing in SYBX?

Key risks for SYBX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does SYBX compare to its competitors?

Compare SYBX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize SYBX's performance and positioning.

What is SYBX's stock price target for 2026?

Our AI model provides price targets for SYBX based on fundamental analysis: Bull case $0.90 (+30%), Base case $0.79 (+15%), Bear case $0.62 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about SYBX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for SYBX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is SYBX's next earnings report?

SYBX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

SYBX - Synlogic Inc

NYSE * Health Care * Biotechnology

$0.69

+$0.01 (+1.47%)

About Synlogic Inc

Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.

SYBX Key Statistics

Market Cap

$8.07M

P/B Ratio

0.63

EPS

$-0.06

Revenue Growth

-1.0%

Employees

How SYBX Compares to Peers

SYBX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
SYBX(This stock)	$8.07M	N/A	-1%	0.0%	-
AMGNAmgen Inc	$181.77B	23.4	0%	0.2%	vs AMGN
GILDGilead Sciences	$166.90B	18.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.59B	26.5	0%	0.4%	vs VRTX
REGNRegeneron Pharmaceuticals	$64.45B	15.0	0%	0.3%	vs REGN
BIIBBiogen Inc	$28.94B	21.1	0%	0.1%	vs BIIB

Synlogic Inc Company Information

Headquarters: Massachusetts; U.S.A
Website: www.synlogictx.com
Sector: Health Care
Industry: Biotechnology

Data Updated: June 2, 2026 at 8:37 AM EDT

Ready to invest in SYBX?

Commission-free trading available. Affiliate links.

SYBX Lician Score

5% confidence

4.0/10

Neutral

SYBX has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates SYBXacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

SYBX Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for SYBX

Dashboard

Enter a ticker to analyze